$AGN News

Last published 1y ago

1y agoLBPH ARNA KYTH AGN+1Sensorion Strengthens Leadership Team with Appointment of Amit Munshi as Chairman of the Board and Independent DirectorBusiness WireRegulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, today
5y agoJNJ MRK PFE TEVA+1The $11 Trillion Healthcare Industry Is About To Change ForeverPR NewswireLONDON, Nov. 4, 2021 /PRNewswire/ -- The $11-trillion healthcare industry is going fully digital, disrupting industry giants & government monopolies, and finally giving the power back to the people. That means no more googling of symptoms for a panic-dri
5y agoRVNC AGNWorldwide Facial Injectable Industry to 2025 - by Type, Generation, End-user and GeographyGlobeNewswireDublin, Feb. 24, 2021 (GLOBE NEWSWIRE) -- The "Facial Injectable Market - Forecasts from 2020 to 2025" report has been added to ResearchAndMarkets.com's offering. The facial injectable market is...
5y agoAMZN AAPL FB GOOGL+5A top Democrat on the House antitrust panel sets sights on Big Pharma after wrapping up tech probeCNBCRep. Joe Neguse, D-Colo., wants the committee to examine the FTC's common approach to approving pharmaceutical mergers.
6y agoAGNNew patent application published for: Inflatable Prostheses and Methods of Making SameUS Patent Applications (USPTO)( 1 of 1 )
6y agoAGNApproval of Microzide, Nda #020504 (Labeling)FDA Approved DrugsApproval Date: 08/20/2020; Drug Name: Microzide, Nda #020504; Active Ingredients: HYDROCHLOROTHIAZIDE; Company: Allergan; Submission Status: Approval; Submission Classification: Labeling; Application Number: 020504
6y agoAGNFDA Updates Analysis of Medical Device Reports of Breast Implant Illness and Breast Implant-Associated LymphomaFDA Press ReleasesToday, the U.S. Food and Drug Administration is providing an update on adverse events reported to the Agency related to breast implants, including breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), and systemic signs and symptoms referred to by patients as breast implant illness (BII), which some patients report after receiving breast implants. The FDA is also qualifying the BREA ...
6y agoAGNNew patent application published for: Method of Enhancing Hair GrowthUS Patent Applications (USPTO)
6y agoAGNNew patent application published for: Methods for Treating HeadacheUS Patent Applications (USPTO)
6y agoAGNApproval of BotoxblaFDA Approved DrugsApproval Date: 07/08/2020; Drug Name: Botoxbla; Company: Allergan; Submission Status: Approval; Application Number: 103000
6y agoAGNNew patent granted for: Immuno-Based Botulinum Toxin Serotype a Activity AssaysUS Patent Applications (USPTO)
6y agoAGNNew patent application published for: Ketorolac Tromethamine Compositions for Treating or Preventing Ocular PainUS Patent Applications (USPTO)( 1 of 1 )
6y agoAGN/R E P E A T -- New Wave Holdings Corp Appoints Dr. Carolyn Myers As VP Of Commerical Development/PR NewswireTORONTO, June 17, 2020 /PRNewswire/ - NEW WAVE HOLDINGS CORP. (the "Company" or "New Wave") (CSE: SPOR) (Frankfurt: 0XM2) (OTC: TRMND), an investment ...
6y agoAGNApproval of Lastacaftnda (Labeling)FDA Approved DrugsApproval Date: 06/09/2020; Drug Name: Lastacaftnda; Company: Allergan; Submission Status: Approval; Submission Classification: Labeling; Application Number: 022134
6y agoAZN-GB GILD MRK PFE+5AstraZeneca contacted Gilead over potential megamergerCNBCBritain's AstraZeneca has approached U.S. rival Gilead Sciences about a possible merger to form one the world's largest drug companies.
6y agoAGNNew patent application published for: Solid Complex, Preparations and Uses ThereofUS Patent Applications (USPTO)
6y agoAGN IPWR SIENFDA issues warning letters to two breast implant manufacturers as part of ongoing efforts to protect patientsFDA Press ReleasesToday, the U.S. Food and Drug Administration issued warning letters to two breast implant manufacturers for failure to comply with various regulatory requirements. The agency issued a warning letter to breast implant manufacturer Allergan of Irvine, California, for failing to comply with requirements—under two separate premarket approval orders—to conduct post-approval studies to assess the long-t ...
6y agoAGNApproval of Androdermnda (Labeling)FDA Approved DrugsApproval Date: 05/11/2020; Drug Name: Androdermnda; Company: Allergan; Submission Status: Approval; Submission Classification: Labeling; Application Number: 020489
6y agoAGNAbbVie Inc. Completes Acquisition of Allergan plcPR NewswireNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF...
6y agoAGNThe Allergan Foundation Doubles its COVID-19 Response Donations to $4.0 MillionPR NewswireAllergan plc (NYSE: AGN) today announced that The Allergan Foundation has fast-tracked another $2 million dollars in charitable grants for community...
6y agoUTX VIAC ABC BMY+24Stocks making the biggest moves in the premarket: Raytheon, ViacomCBS, Moderna, JetBlue & moreCNBCThe stocks making the biggest moves in premarket trading include Raytheon, ViacomCBS, Moderna, JetBlue, and more.
6y agoLYFT SAVE ETSY DXCM+6Stocks making the biggest moves after hours: Spirit Airlines, Etsy, Paypal and moreCNBCCheck out the companies making headlines after the bell.
6y agoGM CVS NYT SHOP-CA+14Stocks making the biggest moves in the premarket: GM, CVS, Shopify, Papa John's, Wendy's & moreCNBCThe stocks making the biggest moves in premarket trading include GM, CVS, Shopify, Papa John's, Wendy's, and more.
6y agoAGN ABBVThe 'beginning of the end' of the health-care recession is 'finally arising,' Jim Cramer saysCNBC"[A]s the country gradually reopens, there are some industries that should do much, much better," the "Mad Money" host said.
6y agoABBV AGNAbbVie and Allergan Receive Clearance from U.S. Federal Trade Commission for AbbVie's Acquisition of AllerganPR NewswireAbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, and Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today...
6y agoAGN AGN20A AGN21 AGN23A+3Announcement relating to the voluntary delisting of Allergan NotesPR NewswireNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF...
6y agoAGNNew patent application published for: Lighter Weight ImplantUS Patent Applications (USPTO)
6y agoAGNChina Gives Greenlight to Allergan's XEN® Registration for the Surgical Management of Refractory GlaucomaPR NewswireAllergan plc (NYSE: AGN) today announced China's National Medical Products Administration (NMPA) approved the registration of Allergan's XEN® Gel...
6y agoAGNAllergan Earns ENERGY STAR® Partner of the Year - Sustained Excellence Award for the Seventh Consecutive YearPR NewswireAllergan plc (NYSE: AGN) today announced it has received the ENERGY STAR® Partner of the Year Sustained Excellence Award for 2020, marking the...
6y agoHLF AXSM AGN JNJMedical Mushroom Companies Expand as People Seek New Mental Health TreatmentsPR NewswireThe search for ways to improve mental health is driving expansion for a variety of companies looking to offer effective solutions, including...
6y agoAGNNew patent granted for: Dissolvable Microneedles for Skin TreatmentUS Patent Applications (USPTO)A skin treatment device is provided including bioerodible polymeric microneedles which are designed to more effectively deliver beneficial agents to the skin. The device includes a flexible substrate and an arrangement, for example, an array, of microneedles projecting from the substrate.
6y agoAGNThe Allergan Foundation Donates $2.0 Million to Community Organizations on Front-Line of COVID-19 ResponsePR NewswireAllergan plc (NYSE: AGN) today announced that The Allergan Foundation has awarded approximately $13 million in charitable grants in 2020 as part of...
6y agoAGNApproval of Aloranda (Labeling)FDA Approved DrugsApproval Date: 03/30/2020; Drug Name: Aloranda; Company: Allergan; Submission Status: Approval; Submission Classification: Labeling; Application Number: 020655
6y agoAGNNew patent application published for: Tissue Expansion DeviceUS Patent Applications (USPTO)( 1 of 1 )
6y agoAGNNew patent application published for: Methods for Treatment of Masseter Muscle HypertrophyUS Patent Applications (USPTO)
6y agoAGNAllergan Declares Second Quarter 2020 Cash Dividend of $0.74 Per Ordinary SharePR NewswireAllergan plc (NYSE: AGN) today announced that its Board of Directors has declared a cash dividend of $0.74 per ordinary share for the second quarter...
6y agoABBV AGNAbbVie and Allergan Sign Consent Decree Agreement with Federal Trade Commission Staff on Pending TransactionPR NewswireAbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, and Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today...
6y agoAGNAnnouncement under the Irish Takeover Rules: Relevant Securities in Issue - March 10, 2020PR NewswireNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF...
6y agoHLF BTAI AGN AXSMCompanies Around the World Broaden Offerings to Enhance Mental Health, Wellness OptionsPR NewswireProduct offerings focused on enhancing mental health and wellness are broadening as companies that are committed to helping consumers are looking for ...
6y agoAGNAllergan Receives FDA Approval for DURYSTA™ (bimatoprost implant) the First and Only Intracameral Biodegradable Sustained-Release Implant to lower Intraocular Pressure in Open-Angle Glaucoma or Ocular Hypertension PatientsPR NewswireAllergan plc (NYSE: AGN), a leading global pharmaceutical company with more than 70 years of heritage in eye care, today announced that the U.S. Food ...
6y agoAGNNew patent application published for: Compositions Containing Alpha-2-Adrenergic Agonist ComponentsUS Patent Applications (USPTO)( 1 of 1 )
6y agoAGNNew patent application published for: Compositions and Methods for Treating Presbyopia, Mild Hyperopia, and Irregular AstigmatismUS Patent Applications (USPTO)( 1 of 1 )
6y agoAGNNew patent application published for: Biodegradable Alpha-2 Agonist Polymeric Implants and Therapeutic Uses ThereofUS Patent Applications (USPTO)( 1 of 1 )
6y agoAGN EDITAllergan and Editas Medicine Announce Dosing of First Patient in Landmark Phase 1/2 Clinical Trial of CRISPR Medicine AGN-151587 (EDIT-101) for the Treatment of LCA10GlobeNewswireAGN-151587 (EDIT-101) is the first in vivo CRISPR medicine to be administered to patients Additional patient enrollment to the BRILLIANCE Clinical Trial is ongoing DUBLIN, Ireland and CAMBRIDGE,...
6y agoAGNApproval of Durystanda (Type 3 - New Dosage Form)FDA Approved DrugsApproval Date: 03/04/2020; Drug Name: Durystanda; Company: Allergan; Submission Status: Approval; Submission Classification: Type 3 - New Dosage Form; Application Number: 211911
6y agoNOVN-CH AGN AZN-GB SAN-FR+1Coronavirus cases hit 80,370. Here's why the health sector is so woefully unpreparedCNBCOn Tuesday the number of confirmed coronavirus cases worldwide hit 80,370 and is continuing its global spread. The health sector, woefully unprepared to handle the outbreak, is trying to develop a vaccine. BioAegis Therapeutics' Steve Cordovano explains why the odds are against them.
6y agoAGNAllergan to Present New Data for Investigational Bimatoprost Sustained-Release at American Glaucoma Society Annual MeetingPR NewswireAllergan plc, (NYSE: AGN), a leading global pharmaceutical company with a more than 70-year heritage in ophthalmology, will present new data from...
6y agoAGNAnnouncement under the Irish Takeover Rules: Relevant Securities in Issue - February 14, 2020PR NewswireNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF...
6y agoAGNAnnouncement under Rule 8.1(a) of the Irish Takeover Rules: Dealings by Offerors, Offerees or Parties Acting in Concert With Them for Themselves or for Discretionary ClientsPR NewswireAp9 APPENDIX 3 DISCLOSURE FORMS FORM 8.1(a)&(b)(i) IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER PANEL ACT,...
6y agoAGNAllergan Reports Fourth Quarter and Full-Year 2019 Financial ResultsPR NewswireAllergan plc (NYSE: AGN) today reported its full-year and fourth quarter 2019 financial results including full-year 2019 GAAP net revenues of $16.1...